Enhanc3D Genomics Ltd

Enhanc3D Genomics was spun out from the laboratories of Dr. Stefan Schoenfelder and Professor Peter Fraser, who pioneered research into the dynamic spatial organisation of the genome at the Babraham Institute in Cambridge, UK.

Our mission is to unlock the full potential of the human genome’s 3D organisation for target and biomarker discovery.

Our proprietary GenLink3D platform uses capture Hi-C technologies to profile this 3D genome folding at high resolution for all genes and their enhancers simultaneously. The platform thus links gene enhancers and non-coding genetic variants to their target genes, unlocking their potential for therapeutic discovery; genetically supported drug targets are twice as likely to succeed in clinical trials (Sanseau et al., 2015).